| Literature DB >> 32626643 |
Reza Eivazzadeh-Keihan1, Ehsan Bahojb Noruzi2, Fateme Radinekiyan1, Milad Salimi Bani3, Ali Maleki1, Behrouz Shaabani2, Mohammad Haghpanahi3.
Abstract
One of the most common phenol-formaldehyde cyclic oligomers from hydroxyalkylation reactions that exhibit supramolecular chemistry are calixarenes. These macrocyclic compounds are qualified to act as synthetic catalysts due to their specific features including being able to form host-guest complexes, having unique structural scaffolds and their relative ease of chemical modifications with a variety of functions on their upper rim and lower rim. Here, a functional magnetic nanocatalyst was designed and synthesized by using a synthetic amino-functionalized calix[4]arene. Its catalytic activity was evaluated in a one-pot synthesis of 2-amino-4H-chromene derivatives. Besides, this novel magnetic nanocatalyst was characterized by spectroscopic and analytical techniques such as FT-IR, EDX, FE-SEM, TEM VSM, XRD analysis.Entities:
Keywords: 2-amino-4H-chromene; calixarenes; heterogeneous catalysis; sonochemistry; supramolecular chemistry
Year: 2020 PMID: 32626643 PMCID: PMC7327476 DOI: 10.1002/open.202000005
Source DB: PubMed Journal: ChemistryOpen ISSN: 2191-1363 Impact factor: 2.911
Scheme 1Schematic preparation of core‐shell MNCACAs and its catalytic activity in one‐pot three‐components synthesis of 2‐amino‐4H‐chromene derivatives.
Figure 1FT‐IR spectra of (a) unfunctionalized Fe3O4 NPs, (b) Fe3O4/SiO2, (c) Fe3O4/SiO2/CPTMS, (d) MNCACAs.
Figure 2EDX spectrum of MNCACAs.
Figure 3(a) FE‐SEM image, (b) TEM image of MNCACAs, (c) Histogram of particle size distribution of MNCACAs.
Figure 4(a) XRD pattern of MNCACAs, (b) reference of synthetic MNPs in the structure of MNCACAs
Figure 5Hysteresis loop curves of (a) unmodified Fe3O4 NPs and (b) MNCACAs.
Optimization of different parameters due to considering the model reaction.[a]
|
Entry |
Catalyst/[mg] |
Solvent |
Time/[min] |
Condition/Temperature/[°C] |
Yield[b]/[%] |
|---|---|---|---|---|---|
|
1 |
– |
EtOH |
90 |
r.t./25 |
N.R |
|
2 |
– |
EtOH |
90 |
Ultrasonic bath/25 |
N.R |
|
3 |
MNCACAs 10.00 mg |
EtOH |
60 |
r.t./25 |
66 % |
|
4 |
Fe3O4 NPs 10.00 mg |
EtOH |
15 |
Ultrasonic bath/25 |
20 % |
|
5 |
Amino‐functionalized calix[4]arene 10.00 mg |
EtOH |
15 |
Ultrasonic bath/25 |
40 % |
|
6 |
MNCACAs 10.00 mg |
EtOH |
15 |
Ultrasonic bath/25 |
84 % |
|
7 |
MNCACAs 20.00 mg |
EtOH |
15 |
Ultrasonic bath/25 |
93 % |
|
8 |
MNCACAs 30.00 mg |
EtOH |
15 |
Ultrasonic bath/25 |
86 % |
|
9 |
MNCACAs 40.00 mg |
EtOH |
15 |
Ultrasonic bath/25 |
86 % |
|
10 |
MNCACAs 20.00 mg |
EtOH |
10 |
Ultrasonic bath/25 |
80 % |
|
11 |
MNCACAs 20.00 mg |
EtOH |
20 |
Ultrasonic bath/25 |
93 % |
|
12 |
MNCACAs 20.00 mg |
EtOH |
30 |
Ultrasonic bath/25 |
93 % |
|
13 |
MNCACAs 20.00 mg |
Dichloromethane |
15 |
Ultrasonic bath/25 |
68 % |
|
14 |
MNCACAs 20.00 mg |
acetone |
15 |
Ultrasonic bath/25 |
66 % |
|
15 |
MNCACAs 20.00 mg |
DMF |
15 |
Ultrasonic bath/25 |
56 % |
|
16 |
MNCACAs 20.00 mg |
methanol |
15 |
Ultrasonic bath/25 |
60 % |
|
17 |
MNCACAs 20.00 mg |
Water |
15 |
Ultrasound/25 |
85 % |
[a] The model reaction condition: benzaldehyde (1 mmol), dimedone (1 mmol), malononitrile (1.5 mmol), ethanol (7 mL), ultrasonic bath condition at room temperature (25 °C). [b] Isolated yield.
Synthesis of 2‐amino‐4H‐chromene derivatives by using catalytic performance of MNCACAs.
|
Entry |
Aldehyde |
Product |
Time/[min] |
Yield[a]/[%] |
Melting point/[°C] Observed |
Melting point [°C] Reported |
|---|---|---|---|---|---|---|
|
1 |
benzaldehyde |
|
20 |
93 |
228–230 |
229–231 |
|
2 |
4‐methylbenzaldehyde |
|
25 |
88 |
218–220 |
217–219 |
|
3 |
2‐methoxybenzaldehyde |
|
25 |
87 |
198–200 |
198–199 |
|
4 |
4‐hydoxybenzaldehyde |
|
25 |
85 |
206–207 |
207–208 |
|
5 |
2,4‐dihydroxybenzaldehyde |
|
30 |
85 |
250–252 |
249–251 |
|
6 |
2,4‐dichlorobenzaldehyde |
|
15 |
94 |
209–2011 |
208–210 |
|
7 |
3‐nitrobenzaldehyde |
|
10 |
95 |
211–213 |
211–213 |
|
8 |
2,6‐dichlorobenzaldehyde |
|
15 |
92 |
249–251 |
250–252 |
|
9 |
4‐chlorobenzaldehyde |
|
18 |
90 |
207–209 |
207–209 |
|
10 |
4‐bromobenzaldehyde |
|
20 |
90 |
205–207 |
204–206 |
|
11 |
4‐nitrobenzaldehyde |
|
10 |
92 |
158–160 |
157–159 |
|
12 |
4‐cyanobenzaldehyde |
|
15 |
95 |
227–229 |
226–228 |
[a] Isolated yield.
Evaluation of catalytic activity of synthetic MNCACAs with other reported studies in synthesis of 2‐amino‐4H‐chromene derivatives.[a]
|
Entry |
Catalyst |
Amount of catalyst/[mg] |
Solvent/Temperature condition |
Time/[min] |
Yield[b]/[%] |
Reference |
|---|---|---|---|---|---|---|
|
1 |
Fe3O4@MCM‐41@Zr‐piperazine‐MNPs |
30.00 mg |
EtOH/H2O/75 °C |
40 |
74 % |
[42] |
|
2 |
AIL@MNP |
60.00 mg |
Solvent‐free/90 °C |
25 |
89 % |
[45] |
|
3 |
Mg(ClO4)2 |
25 w% |
EtOH/Reflux |
180 |
90 % |
[46] |
|
4 |
RE(POF)3 |
5 mol % |
EtOH/60 °C |
300 |
90 % |
[47] |
|
5 |
MgO |
0.25 g |
EtOH/H2O/Reflux |
30 |
92 % |
[48] |
|
6 |
MNCACAs |
20.00 mg |
EtOH/Ultrasonic bath (25 °C) |
15 |
93 % |
Present study |
[a] The model reaction conditions: benzaldehyde (l mmol), dimedone (1 mmol), malononitrile (1.5 mmol), MNCACAs catalyst (20.00 mg), ethanol (7 mL), ultrasonic bath condition at room temperature (25 °C). [b] Isolated yield.
Scheme 2Plausible mechanism for synthesis of 2‐amino‐4H‐chromene derivatives by using MNCACAs.
Figure 6Catalytic reusability of synthetic MNCACAs in synthesis of 4 a after 5 catalytic run.